SCHEMBL6420701

SCHEMBL6420701

CCNC(=O)Nc1cncc(N2CCN(CCO)CC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 3/20 0.42
SIK1 P57059 3/20 0.42
SIK2 Q9H0K1 3/20 0.42
SIK3 Q9Y2K2 3/20 0.42
FLT3 P36888 3/20 0.39
AURKA O14965 2/20 0.39
KDR P35968 2/20 0.39
PIK3CA P42336 5/20 0.39
MAPK1 P28482 4/20 0.39
MAPK8 P45983 4/20 0.39
MAPK9 P45984 4/20 0.39
MAPK10 P53779 4/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
HTR2A P28223 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6415598 0.76 KDM4E (0.46) KDM4EALDH1A1LMNA
SCHEMBL12813911 0.72 HTR2A (0.57) KDM4EALDH1A1HTR1ADRD2HTR2A
SCHEMBL6208080 0.72 PIK3CA (0.47) PIK3CAMAPK1MAPK8MAPK9MAPK10
SCHEMBL5447527 0.69 PIK3CA (0.61) PIK3CAMAPK1MAPK8MAPK9MAPK10
SCHEMBL4341121 0.69 PIK3CA (0.57) PIK3CAMAPK1MAPK8MAPK9MAPK10
SCHEMBL10672091 0.66 HTR2A (0.53) KDM4EALDH1A1HTR1ADRD2HTR2A
SCHEMBL14506589 0.66 MAPK1 (0.59) PIK3CAMAPK1MAPK8MAPK9MAPK10
SCHEMBL4353813 0.66 PIK3CA (0.53) PIK3CAMAPK1MAPK8MAPK9MAPK10
SCHEMBL24993525 0.65 DRD2 (0.40) KDM4EALDH1A1DRD2SIGMAR1
SCHEMBL24993370 0.65 PTPN11 (0.44) MAPK1ALDH1A1DRD2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050267126-A1 Compounds derived from aryl carbamates, preparation thereof and uses of same CEREP (FR) 2005-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050267126-A1 Compounds derived from aryl carbamates, preparation thereof and uses of same HTR4, HTR2B, HTR1B ABL1 1146/4885SIK1 4639/4885SIK2 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.